Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qomel CoSAU:9600 +2.08%22 Net Margin % is 8.01% as of Dec. 2025, which is 52% below its 10-year median of 16.68. GuruFocus rates SAU:9600 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Qomel Co ranks better than 81.48% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Qomel Co's Net Income for the
six
months ended in Dec. 2025 was ﷼4.9 Mil. Qomel Co's Revenue for the
six
months ended in Dec. 2025 was ﷼61.0 Mil. Therefore, Qomel Co's net margin for the quarter that ended in Dec. 2025 was 8.01%.
The historical rank and industry rank for Qomel Co's Net Margin % or its related term are showing as below:
SAU:9600'
s Net Margin % Range Over the Past 10 Years
Min: 11.31 Med: 16.68 Max: 17.68
Current: 11.31
SAU:9600's Net Margin % is ranked better than 81.48% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 2.905
vs SAU:9600: 11.31
Qomel Co (SAU:9600) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Qomel Co Net Margin % Related Terms
Qomel Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Qomel Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Qomel Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qomel Co Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qomel Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Qomel Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qomel Co (SAU:9600) has a Net Margin % of 8.01% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Qomel Co and its competitors. This is 52% below median its historical median of 16.68. Over the past decade, Qomel Co's Net Margin % has ranged from 11.31 to 17.68. According to the industry distribution chart, Qomel Co ranks #123 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 18.5%.
Is Qomel Co's Net Margin % too high?
Qomel Co's current Net Margin % of 8.01% is 52% below median its 10-year median of 16.68. Over the past 10 years, this metric has ranged from a low of 11.31 to a high of 17.68. The Healthcare Providers & Services industry median Net Margin % is 2.91. Qomel Co's value of 8.01% is 175.7% above this industry median. Based on the distribution chart, Qomel Co ranks #123 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Qomel Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Qomel Co's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qomel Co ranks #123 out of 664 companies for Net Margin %. This places Qomel Co in the top 19% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.91. Qomel Co's value of 8.01% is 175.7% above this benchmark. Historically, Qomel Co's own Net Margin % has ranged from 11.31 to 17.68 over the past decade. While the company's 10-year median is 16.68 vs. the industry median of 2.91, Qomel Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.91, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qomel Co's current Net Margin % of 8.01% is 175.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Qomel Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qomel Co's current Net Margin % is 8.01%, which is 52% below median its own 10-year median of 16.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qomel Co stock overvalued right now?
Qomel Co (SAU:9600) has a current Net Margin % of 8.01%. The current Net Margin % is 8.01%, which is 52% below median its 10-year median of 16.68 and 175.7% above the Healthcare Providers & Services industry median of 2.91. Qomel Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Qomel Co (SAU:9600), the current Net Margin % is 8.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Qomel Co is a Saudi Arabian-based healthcare company that provides high-quality medicines and innovative medical services whose core business focuses on institutional and government supply through a professional field force and an in-depth knowledge of the local business environment They offer services such as pharmaceutical and medical supplies.
22GF Score
Get the complete analysis for SAU:9600
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9600 has been successfully added to your 
